The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preoperative botensilimab (BOT) with or without balstilimab (BAL) for patients with resectable locally advanced pMMR or dMMR colon cancer: Results from the UNICORN trial by GONO.
 
Filippo Ghelardi
No Relationships to Disclose
 
Margherita Ambrosini
No Relationships to Disclose
 
Alessandra Raimondi
Consulting or Advisory Role - MSD
Speakers' Bureau - Elma Academy; SERVIER
Travel, Accommodations, Expenses - Amgen; Merck Serono
 
Giovanna Sabella
No Relationships to Disclose
 
Riccardo Cerantola
No Relationships to Disclose
 
Federica Palermo
No Relationships to Disclose
 
Samantha Di Donato
Consulting or Advisory Role - Amgen; MSD; SERVIER
Speakers' Bureau - Amgen; MSD; SERVIER
Travel, Accommodations, Expenses - Bayer; SERVIER
 
Daniele Spada
No Relationships to Disclose
 
Stefano Tamberi
No Relationships to Disclose
 
Eleonora Perissinotto
No Relationships to Disclose
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Pierre Fabre; SERVIER
Speakers' Bureau - Bayer; BMS; Eisai; Lilly; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Alessandro Passardi
No Relationships to Disclose
 
Emiliano Tamburini
Consulting or Advisory Role - Amgen; AstraZeneca; SERVIER
 
Riccardo Rosati
Leadership - T-One Therapeutics
 
Andrea Sartore-Bianchi
Honoraria - Guardant Health
Consulting or Advisory Role - Bayer; Pierre Fabre; SERVIER; Takeda
 
Marcello Guaglio
Travel, Accommodations, Expenses - Rand Italy (Inst)
 
Chiara Cremolini
Honoraria - Amgen; Bayer; GlaxoSmithKline; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; Bicara Therapeutics; MSD; Nordic Bioscience; Pierre Fabre; Revolution Medicines; Roche; Rottapharm Biotech; Takeda
Speakers' Bureau - Merck; MSD; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER
 
Isacco Montroni
Speakers' Bureau - Fresenius Kabi; Olympus Medical Systems
Travel, Accommodations, Expenses - Olympus Medical Systems
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Beigene; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Helyon; Incyte; Lilly; Merck Serono; MSD; Nimbus Therapeutics; Rottapharm Biotech; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi-Sankyo; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi-Sankyo; Gilead Sciences; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals,; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer; Pierre Fabre; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst); Rottapharm Biotech (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; Takeda Science Foundation